Mumbai-based online medicine delivery platform PharmEasy has raised a $220-million funding round at a $700-million valuation, led by Singapore government-owned Temasek. The round saw participation from Canada-based pension fund CDPQ, KB Financial Group and other investors including Infosys Co-founder Nandan Nilekani. Launched in 2015, PharmEasy had raised $50 million in Series C funding in 2018.